Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

SUPN holding history

Supernus Pharmaceuticals, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings

Shares (Q2 2026)
205
Value
$9.54K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SUPN by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026205$9.54K<0.1%−1,635−88.9%ReducedHolders
Q1 20261,840$95.1K<0.1%+63+3.5%AddedHolders
Q4 20251,777$88.3K<0.1%−618−25.8%ReducedHolders
Q3 20252,395$114.5K<0.1%−3,170−57.0%ReducedHolders
Q2 20255,565$175.4K<0.1%−596−9.7%ReducedHolders
Q1 20256,161$201.8K<0.1%+104+1.7%AddedHolders
Q4 20246,057$219.0K<0.1%+18+0.3%AddedHolders
Q3 20246,039$188.3K<0.1%+76+1.3%AddedHolders
Q2 20245,963$159.5K<0.1%−88−1.5%ReducedHolders
Q1 20246,051$206.4K<0.1%+453+8.1%AddedHolders
Q4 20235,598$162.0K<0.1%−68−1.2%ReducedHolders
Q3 20235,666$156.2K<0.1%−385−6.4%ReducedHolders
Q2 20236,051$181.9K<0.1%−218−3.5%ReducedHolders
Q1 20236,269$227.1K<0.1%+923+17.3%AddedHolders
Q4 20225,346$190.7K<0.1%−513−8.8%ReducedHolders
Q3 20225,859$198.0K<0.1%−835−12.5%ReducedHolders
Q2 20226,694$194.0K<0.1%−2,879−30.1%ReducedHolders
Q1 20229,573$309.0K<0.1%−3,077−24.3%ReducedHolders
Q4 202112,650$369.0K<0.1%−266−2.1%ReducedHolders
Q3 202112,916$344.0K<0.1%−769−5.6%ReducedHolders
Q2 202113,685$421.0K<0.1%+619+4.7%AddedHolders
Q1 202113,066$342.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.